Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoQ10 in Charcot-Marie-Tooth Disease
NCT00541164Phase 2Completed
- Sponsor
- Memorial Medical Center
- Start
- Sep 2007
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Charcot-Marie-Tooth disease (CMT) comparing CoQ10 Continuous with Placebo to CoQ10 Crossover (2 arms). Primary endpoint: Changes in weakness, fatigue and pain at 60 weeks. Started Sep 2007; status: completed.
02
Drugs
coenzyme q10
03
Conditions
Charcot-Marie-Tooth disease (CMT)
Beyond the preview
Go deeper on NCT00541164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541164.